Fujiwara Yoshiyuki, Tamura Shigeyuki, Yoshioka Setsuko, Okada Yoshihiro, Takiguchi Shuji, Yano Masahiko, Yasuda Takushi, Monden Morito
Dept. of Surgery and Clinical Oncology, Graduate School of Medicine, Osaka University.
Gan To Kagaku Ryoho. 2002 Dec;29(13):2555-9.
The importance of chemotherapy in the treatment of gastric cancer has increased after the appearance of more effective new agents such as TS-1. Therefore, the development of second line chemotherapy following TS-1 administration is needed urgently. Recently, we treated three cases of advanced and recurrent gastric cancers, using paclitaxel after TS-1 treatment. We herein describe these cases and discuss the therapeutic effect of paclitaxel and drug-related side effects in these patients.
随着TS-1等更有效的新型药物的出现，化疗在胃癌治疗中的重要性日益增加。因此，迫切需要开发TS-1给药后的二线化疗方案。最近，我们对3例晚期复发性胃癌患者在TS-1治疗后使用了紫杉醇进行治疗。在此，我们描述这些病例，并讨论紫杉醇在这些患者中的治疗效果及药物相关副作用。
Zotero 插件